Search results for "Cancer"

showing 10 items of 11546 documents

The lower the expectations in controlling the symptoms of advanced cancer patients, the better the clinical response.

2020

Aim The aim of this study was to compare patients' global impression (PGI) and the achievement of personalised symptom goal response (PSGR), after a comprehensive palliative care treatment in advanced cancer patients having high (HPSG) and low symptom goals (LPSG). Patients and methods Advanced cancer patients admitted to palliative care units rated symptoms intensity by the Edmonton Symptom Assessment Score (ESAS) at admission and then after one week of comprehensive palliative care treatment. For each symptom, patients were divided into two groups, according to their patient symptom goal (PSG): ≥4 (HPSG), and 0-2 (LPSG). PGI and PSGR were evaluated after one week of palliative care. The M…

medicine.medical_specialtyWeaknessPalliative careMEDLINESymptom assessment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineNeoplasmsmedicineHumans030212 general & internal medicineAgedMotivationbusiness.industryPalliative CareNeoplasms therapyGeneral MedicineAssessment scaleAdvanced cancerHospitalizationDeliriumNAmedicine.symptomSymptom AssessmentbusinessHumanInternational journal of clinical practiceREFERENCES
researchProduct

What is the accuracy of the surgical guide in the planning of orthognathic surgeries? A systematic review.

2021

BACKGROUND To investigate the true accuracy of the surgical guide in the planning of orthognathic surgeries, which are performed worldwide. MATERIAL AND METHODS A systematic search was conducted in the PubMed database, Web of science, Scopus and Embase, covering August 2020 to January 2021. Studies that included patients with dentofacial deformity including anteroposterior, vertical and asymmetry problems who were undergoing an orthognathic surgery procedure were included; QUADAS-2 was used to determine the risk of bias by analyzing the quality of the studies. A PRISMA (flowchart) was created to show the study selection, keywords, nomination processes, and inclusion and exclusion criteria. …

medicine.medical_specialtyWeb of sciencemedicine.medical_treatmentOrthognathic surgeryDentofacial DeformityImaging Three-DimensionalmedicineHumansMedical physicsGeneral DentistryUNESCO:CIENCIAS MÉDICASoral squamous cell carcinoma (oscc)business.industryOrthognathic Surgical ProceduresOrthognathic Surgeryvitamin doral canceroral potentially malignant disorders (opmds)OtorhinolaryngologyVirtual planningSurgery Computer-AssistedInclusion and exclusion criteriaPrinting Three-DimensionalComputer-Aided DesignSurgerybusinessSystematic searchMedicina oral, patologia oral y cirugia bucal
researchProduct

Salmon-colored and white areas on dermoscopy as supportive findings in the diagnosis of primary cutaneous marginal zone lymphoma

2019

medicine.medical_specialtyWhite (horse)business.industryCancerlymphomaArticlesDermatologymedicine.diseaseDermatologyLymphomaOncologyRL1-803GeneticsmedicinecancerPrimary cutaneous marginal zone lymphomadermoscopybusinessMolecular BiologyDermatology Practical & Conceptual
researchProduct

Whole-body magnetic resonance imaging (WB-MRI) in oncology: an Italian survey.

2019

Purpose: To perform a survey among all members of the Italian Society of Medical and Interventional Radiology (SIRM) to assess how whole-body MRI (WB-MRI) is performed in oncologic patients in Italy. Methods: On March 2019, we administered an online poll to all SIRM members about their use of WB-MRI in 2018 asking 15 questions regarding oncologic indications, imaging protocol, use of contrast media, experience in WB-MRI, duration of scan time and reporting time. Results: Forty-eight members participated to the survey. WB-MRIs/total MRIs ratio was 1%. Lymphoma was the most common indication (17/48, 35%), followed by myeloma and prostate cancer, with these three tumors representing the most c…

medicine.medical_specialtyWhole body imagingContrast MediaGadolinium030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicineBreast cancerNeoplasmsSurveys and QuestionnairesmedicineHumansRadiology Nuclear Medicine and imagingWhole Body ImagingPractice Patterns Physicians'CancerNeuroradiologyWhole-body imagingmedicine.diagnostic_testbusiness.industryCancerInterventional radiologyMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingItaly030220 oncology & carcinogenesisDiffusion-weighted imagingRadiologybusinessDiffusion MRILa Radiologia medica
researchProduct

EP1155 Endoscopic near infrared and indocyanine green to verify the viability of the subcutaneous flap for vulvar cancer

2019

Introduction/Background Vulvar cancer often requires radical vulvectomy with subsequent vulvar flap due to tumor aggressiveness and a high percentage of relapses. Approximately in 20–60% of cases, there are post-operative complications ranging from infection to wound dehiscence, lymphocele and flap necrosis that often require reoperation. Several methods have been described to verify the vitality of the flap, especially in plastic surgery, but these are often expensive and require specific machinery that is not generally present in a gynecological clinic. We present a viability verification of V-Y fasciocutaneous advancement flap for vulvar reconstruction by Endoscopic Near-Infrared and Ind…

medicine.medical_specialtyWound dehiscencebusiness.industryInguinal lymphadenopathyVulvar cancermedicine.diseaseSurgeryRadical hemivulvectomychemistry.chemical_compoundPlastic surgeryLymphocelechemistryRadical Vulvectomymedicinemedicine.symptombusinessIndocyanine greenePoster
researchProduct

Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT

2017

// Cedric Rossi 1, 2 , Morgane Mounier 3 , Pauline Brice 4 , Violaine Safar 5 , Emmanuelle Nicolas-Virelizier 6 , Philippe Rey 6 , Aspasia Stamatoullas-Bastard 7 , Marion Alcantara 7 , Adrien Chauchet 8 , Emilie Reboursiere 9 , Lauriane Filliatre 10 , Aurore Perrot 10 , Sylvain Garciaz 11 , Gilles Salles 6 , Bertrand Coiffier 6 , Herve Ghesquieres 5, 6 and Rene-Olivier Casasnovas 1, 12 1 Hematologie Clinique, CHU Le Bocage, Dijon, France 2 INSERM UMR 1037 - Cancer Research Center of Toulouse, Toulouse, France 3 Registre des Hemopathies Malignes de Cote d’Or, EA4184, Universite de Bourgogne, Dijon, France 4 Hematologie Clinique, CHU Paris-GH St-Louis Lariboisiere F-Widal - Hopital Saint-Loui…

medicine.medical_specialty[SDV.CAN]Life Sciences [q-bio]/CancerComputed tomographyStage iiinfradiaphragmatic[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health sciences0302 clinical medicinemedicineIn patientStage (cooking)radiotherapyComputingMilieux_MISCELLANEOUSGynecologyPET-CTmedicine.diagnostic_testbusiness.industryLarge seriesOncologyABVD030220 oncology & carcinogenesisHodgkin lymphomabusinessHodgkin lymphoma030217 neurology & neurosurgeryResearch Papermedicine.drug
researchProduct

Definition of the Rectum An International, Expert-based Delphi Consensus

2019

Mini: A radiological, anatomic distinction between the rectum and sigmoid colon was agreed by consensus of international experts in rectal cancer using the Delphi Technique. Use of this landmark, “the sigmoid take-off,” may harmonize efforts in research and clinical practice to improve patient outcomes. Background: The wide global variation in the definition of the rectum has led to significant inconsistencies in trial recruitment, clinical management, and outcomes. Surgical technique and use of preoperative treatment for a cancer of the rectum and sigmoid colon are radically different and dependent on the local definitions employed by the clinical team. A consensus definition of the rectum…

medicine.medical_specialtyanatomyRESECTIONConsensusDelphi TechniqueColorectal cancerAttitude of Health PersonnelDelphi methodRectumMesorectumGUIDELINESdigestive system03 medical and health sciencesAll institutes and research themes of the Radboud University Medical Center0302 clinical medicineColon SigmoidCOLONTumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]MANAGEMENTmedicineHumansPREOPERATIVE RADIOTHERAPYmedicine.diagnostic_testbusiness.industryRectal NeoplasmsGeneral surgeryRectumSigmoid colonMagnetic resonance imagingSigmoid functionmedicine.diseaseCANCERdigestive system diseasessigmoidmedicine.anatomical_structure030220 oncology & carcinogenesisRadiological weapon030211 gastroenterology & hepatologySurgerybusinessPOSTOPERATIVE CHEMORADIOTHERAPYMRIAnnals of Surgery
researchProduct

Involvement of Different networks in mammary gland involution after the pregnancy/lactation cycle: Implications in breast cancer

2015

Early pregnancy is associated with a reduction in a woman's lifetime risk for breast cancer. However, different studies have demonstrated an increase in breast cancer risk in the years immediately following pregnancy. Early and long-term risk is even higher if the mother age is above 35 years at the time of first parity. The proinflammatory microenvironment within the mammary gland after pregnancy renders an "ideal niche" for oncogenic events. Signaling pathways involved in programmed cell death and tissue remodeling during involution are also activated in breast cancer. Herein, the major signaling pathways involved in mammary gland involution, signal transducer and activator of transcripti…

medicine.medical_specialtybiologyClinical BiochemistryMammary glandCell BiologyTransforming growth factor betamedicine.disease_causemedicine.diseaseBiochemistryChromatin remodelingmedicine.anatomical_structureEndocrinologyBreast cancerInternal medicineGeneticsmedicinebiology.proteinCancer researchInvolution (medicine)Signal transductionCarcinogenesisMolecular BiologyMammary gland involutionIUBMB Life
researchProduct

Identifying the Profile of Helicobacter pylori–Negative Gastric Cancers: A Case-Only Analysis within the Stomach Cancer Pooling (StoP) Project

2022

Abstract Background: The prevalence of Helicobacter pylori–negative gastric cancer (HpNGC) can be as low as 1%, when infection is assessed using more sensitive tests or considering the presence of gastric atrophy. HpNGC may share a high-risk profile contributing to the occurrence of cancer in the absence of infection. We estimated the proportion of HpNGC, using different criteria to define infection status, and compared HpNGC and positive cases regarding gastric cancer risk factors. Methods: Cases from 12 studies from the Stomach cancer Pooling (StoP) Project providing data on H. pylori infection status determined by serologic test were included. HpNGC was reclassified as positive (eight st…

medicine.medical_specialtybiologyEpidemiologybusiness.industryCancerOdds ratioHelicobacter pyloribiology.organism_classificationmedicine.diseaseGastroenterologyConfidence intervalOncologyInternal medicineMedicineCagAHelicobacterFamily historybusinessStomach cancerCancer Epidemiology, Biomarkers & Prevention
researchProduct

Stellenwert des Tumormarkers CA 19–9 in der Differentialdiagnose von Raumforderungen im Pankreaskopf

1996

In 96 patients (ductal pancreatic carcinoma, n = 34; periampullary carcinoma, n = 43; chronic pancreatitis, n = 19) the role of CA 19-9 in the diagnosis of lesions of the head of the pancreas were evaluated. The sensitivity for ductal pancreatic carcinoma was 73.3%, for periampullary carcinoma 48.8%, and specificity was 63.2%. Carcinoembryonic antigen was elevated only in every fifth patient. Even when combining the two tumor markers no increase in sensitivity could be observed. The low specificity of 63%, which decreased to 33% in the case of obstructive jaundice, does not allow adequate preoperative differentiation between cancer patients and those with chronic pancreatitis. In cases of p…

medicine.medical_specialtybiologybusiness.industryCancermedicine.diseaseGastroenterologyCarcinoembryonic antigenmedicine.anatomical_structureInternal medicinemedicinebiology.proteinCarcinomaPancreatitisSurgeryCA19-9Differential diagnosisPancreasbusinessTumor markerDer Chirurg
researchProduct